Grassi Investment Management Q1 2023 vs. Q2 2023 13F Holdings Comparison

Introduction:

The first and second quarters of 2023 have seen some interesting developments in the holdings of Grassi Investment Management. In this blog post, we will analyze the changes in the fund's portfolio and see how they compare between Q1 and Q2. From tech giants like NVIDIA and Apple to healthcare companies like Eli Lilly and Abbott Labs, we will delve into the numbers and discuss the implications for investors.

NVIDIA Corp (NVDA):

NVIDIA Corp. has been a top holding for Grassi Investment Management, and the first two quarters of 2023 have been no exception. While there was a slight decrease in the number of shares held (from 275,300 to 273,950), the value of the holding increased significantly from $76,470 to $115,886, representing a 51.5% change. This suggests increased confidence in the company's growth prospects.

Apple Inc (AAPL):

Apple Inc. has remained a stable holding for Grassi Investment Management, with a negligible decrease in the number of shares held (from 347,422 to 346,553). However, the value of the holding increased from $57,290 to $67,221, indicating a positive outlook on the company's future performance. The 17.3% change reflects the overall bullish sentiment towards Apple.

Microsoft Corp (MSFT):

Microsoft Corp. is another tech giant that deserves attention. Grassi Investment Management held 161,006 shares in Q1, which decreased slightly to 160,477 shares in Q2. However, the value of the holding increased from $46,418 to $54,649, indicating a 17.7% change. This growth suggests that the fund sees Microsoft as a strong player in the technology sector.

Applied Materials Inc (AMAT):

Applied Materials Inc. maintained its position in the fund's portfolio without any changes in the number of shares held (278,316) between Q1 and Q2. However, the value of the holding increased from $34,185 to $40,228, representing a 17.7% change. This indicates the fund's confidence in the company's ability to deliver solid returns.

Eli Lilly & Co (LLY):

Eli Lilly & Co. caught the attention of Grassi Investment Management, as evident from the 36.6% change in the value of the holding. While the number of shares held remained the same (79,412), the value increased from $27,272 to $37,242. This suggests that the fund sees potential in the pharmaceutical giant, which could be driven by new drug developments or positive financial performance.

Visa Inc CL A (V):

Visa Inc. is a financial powerhouse that Grassi Investment Management has shown confidence in. Although there was a minor decrease in the number of shares held (from 101,619 to 101,378), the value of the holding increased from $22,911 to $24,075, indicating a 5.1% change. This shows the fund's positive outlook on the company's growth and resilience in the financial sector.

Conclusion:

Grassi Investment Management made several notable changes in its holdings during the first and second quarters of 2023. While some companies saw minor adjustments in the number of shares held, the overall sentiment towards the portfolio was positive with increased values and strong growth prospects. The fund maintained its position in key tech giants like NVIDIA, Apple, and Microsoft, indicating a continued bullish outlook on the sector. Additionally, investments in healthcare companies such as Eli Lilly and Abbott Labs reflect a belief in the industry's potential. Investors can take cues from these changes and conduct further research to make informed investment decisions.

Disclaimer: The information in this blog post is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Investors should conduct thorough research and seek professional advice before making any investment decisions.